Key result
High-power RF during PVI is associated with ~15% higher 12-month freedom from recurrence vs conventional power.
Why the study?
The study was designed to compare procedural safety and outcomes between high-power and conventional-power atrial radiofrequency applications during pulmonary vein isolation using unipolar signal modification as a local endpoint.
Does high-power radiofrequency ablation improve procedural outcomes and freedom from recurrence compared to conventional-power ablation in patients with paroxysmal atrial fibrillation undergoing PVI?
Cohort (n=120)
Does high-power radiofrequency ablation improve procedural outcomes and freedom from recurrence compared to conventional-power ablation in patients with paroxysmal atrial fibrillation undergoing PVI?
Absolute Event Rate: 88.3% vs 73.3%
p-value: p=0.0423
High-power radiofrequency ablation guided by unipolar signal modification decreases procedural time and improves 12-month freedom from recurrence compared to conventional power in patients with paroxysmal atrial fibrillation.
High-power PVI was associated with higher 12-month freedom from recurrence in this cohort; hypothesis-generating and requires randomized confirmation before practice change.
INTRODUCTION: Negative component abolition of the unipolar signal (unipolar signal modification [USM]) reflects the lesion transmurality. The purpose of this study was to compare the procedural safety and outcome between high-power and conventional-power atrial radiofrequency applications during a pulmonary vein isolation (PVI) using USM as a local endpoint. METHODS AND RESULTS: High-power (50 W) and conventional-power (25-40 W) applications were compared among 120 consecutive patients with paroxysmal atrial fibrillation who underwent a USM-guided PVI. The first 60 patients were treated with conventional-power (CP) group and last 60 with high-power (HP) group. The atrial radiofrequency applications lasted for 5 to 10 seconds (CP group) or 3 to 5 seconds (HP group) after the USM. All procedures were performed using 3D mapping systems with image integration and esophageal temperature monitoring. The baseline characteristics were similar between the two groups. The HP group had fewer acute PV reconnections (62% vs 78%; P = .046) and a reduced procedure time (119.3 ± 28.1 vs 140.1 ± 51.2 minutes; P = .04). Freedom from recurrence after a single ablation procedure without any antiarrhythmic drugs was higher in the HP group than CP group (88.3% vs 73.3% at 12-months after the procedure, log-rank; P = .0423). There were no major complications that required any intervention. CONCLUSIONS: The high-power PVI guided by USM decreased the procedural time and may improve the procedural outcomes without compromising the safety.
No takes yet. Share an insight, caveat, or question.
Ejima et al. (2020) conducted a cohort in paroxysmal atrial fibrillation (n=120). High-power radiofrequency applications vs. Conventional-power (25-40 W) applications for 5 to 10 seconds was evaluated on Freedom from recurrence after a single ablation procedure without any antiarrhythmic drugs at 12-months (p=0.0423). High-power (50 W) radiofrequency applications during pulmonary vein isolation improved 12-month freedom from recurrence compared to conventional power (88.3% vs 73.3%; P=0.0423).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: